Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statement of Shareholders' Equity (Unaudited) (Parenthetical)

v2.4.1.9
Condensed Consolidated Statement of Shareholders' Equity (Unaudited) (Parenthetical) (USD $)
Dec. 31, 2013
Dec. 31, 2012
Common Stock, par value (in dollars per share) $ 0.01us-gaap_CommonStockParOrStatedValuePerShare  
OPKO Health Europe    
Common Stock, par value (in dollars per share) $ 7.52us-gaap_CommonStockParOrStatedValuePerShare
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOHealthEuropeMember
 
Stock price $ 11.60us-gaap_SharePrice
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOHealthEuropeMember
$ 4.12us-gaap_SharePrice
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOHealthEuropeMember
OPKO Brazil    
Stock price $ 6.73us-gaap_SharePrice
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOBrazilMember
 
OPKO Renal    
Stock price $ 7.16us-gaap_SharePrice
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKORenalMember
 
OPKO Biologics    
Stock price $ 8.49us-gaap_SharePrice
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOBiologicsMember
 
OPKO Lab    
Stock price   $ 4.65us-gaap_SharePrice
/ us-gaap_BusinessAcquisitionAxis
= opk_OPKOLabMember